Planful of US to invest $120m in expanding its Hyderabad R&D hub

Aurobindo Pharma’s stepdown subsidiary, Eugia Steriles Private Ltd, has received its first product approval from the US FDA for Lidocaine Hydrochloride injection. The approval came after an inspection of their new injectables manufacturing facility in Andhra Pradesh. This achievement is pivotal for Aurobindo Pharma’s expansion plans.

Leave a Reply

Your email address will not be published. Required fields are marked *